EB
MDGL icon

Eastern Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Eastern Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.9K Sell
65
-21
-24% -$10.8K ﹤0.01% 672
2026
Q1 		$45K Hold
86
– – ﹤0.01% 586
2025
Q4 		$50.1K Buy
86
+21
+32% +$10.7K ﹤0.01% 571
2025
Q3 		$29.8K Hold
65
– – ﹤0.01% 657
2025
Q2 		$19.7K Hold
65
– – ﹤0.01% 680
2025
Q1 		$21.5K Hold
65
– – ﹤0.01% 679
2024
Q4 		$20.1K Hold
65
– – ﹤0.01% 694
2024
Q3 		$13.8K Buy
+65
New +$16.6K ﹤0.01% 729

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eastern Bank's MDGL Position: Q2 2026 in Review

Eastern Bank reduced its Madrigal Pharmaceuticals (MDGL) stake by 24% in Q2 2026, selling an estimated $10.8K and leaving 65 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Eastern Bank first reported a position in MDGL in Q3 2024 and has held it in 8 quarters since. The position peaked at $50.1K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Eastern Bank held 65 shares of Madrigal Pharmaceuticals worth $34.9K as of Q2 2026.
  • Eastern Bank sold 21 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $10.8K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #672 holding.
  • Eastern Bank first reported a position in Madrigal Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Eastern Bank's Madrigal Pharmaceuticals position peaked at $50.1K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.